The DOI matches its Crossref record.
Raising the Technological Level: The Scope for API, Excipients, and Biologicals Manufacture in Africa
Open accessAbstract
This chapter discusses raising the technological scope for locally manufacturing active pharmaceutical ingredients (APIs), excipients and biologicals in Africa — a hitherto nascent industry. It also discusses African drug development and manufacturing through the standardized use of ‘reverse pharmacology’ to bring new treatments for neglected diseases to the point of regulatory approvals. Currently there is very modest production of APIs on the African continent, although a few significant projects exist, 1 (such as LaGray in Ghana and Fine Chemicals in South Africa), or are in the planning stages. 2 Generic producers in India and China supply nearly all of the APIs used in African pharmaceutical manufacturing. Most African companies cannot afford the heavy investment and research and development activities required for API production. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the cost of excipients (which has been shown to average $2.63 per kilogram of finished pharmaceutical product [18])”
From Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Levi, J., Wang, J., Venter, F., & Hill, A. (2023) · Obesity · doi:10.1002/oby.23725 · Cited by 69
“63 per kilogram of finished pharmaceutical product [18]), and an average Indian taxation on profit of 27%, as well as allowing for an overall 10% margin for profit.”
BackgroundCurrent prices versus minimum costs of production for CFTR modulators
Guo, J., Wang, J., Zhang, J., Fortunak, J., & Hill, A. M. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.04.007 · Cited by 64
Self-citationYang, Y., Husain, L., & Huang, Y. (2024) · Globalization and Health · doi:10.1186/s12992-024-01089-x · Cited by 12
Empowering health sovereignty in Africa through innovations for self-reliant healthcare
Abdullahi, Y. B., Ahmed, N., Bashir, S., Abdi, Y. H., Abdi, M. S., Alhammadi, O. A. S., Okesanya, O. J., Agboola, A. O., & Ahmed, M. M. (2025) · Discover Public Health · doi:10.1186/s12982-025-01184-3 · Cited by 12
“Although India’s pharmaceutical exports to Africa provide cost-effective alternatives to Western medicines, many African nations remain dependent on imported active pharmaceutical ingredients, limiting genuine production sovereignty [43, 44].”
Barrett, W. M., Takkellapati, S., Tadele, K., Martin, T. M., & Gonzalez, M. A. (2019) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b05983 · Cited by 5
Basic Concept and Application of Sampling Procedures
Raval, N., Tambe, V., Kuche, K., Maheshwari, R., & Tekade, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814421-3.00009-9 · Cited by 2
Public Health Security in African Oncology
Kale, D., Joshi, P., & Parris, S. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-1767-0.ch004
Metadata
- Authors
- Fortunak, J., Ngozwana, S., Gebre-Mariam, T., Ellison, T., Watts, P., Emeje, M., & Nytko, F. E.
- Venue
- Making Medicines in Africa
- Publisher
- Palgrave Macmillan UK
- Published
- 2016
- Pages
- 122-143
- OpenAlex
- W2346546411
- Cited by
- 7
- References
- 0
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2019: 1 · 2018: 1
- FWCI
- 3.91
- Type
- book chapter
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Palgrave Macmillan UK eBooks (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Social Sciences › Business, Management and Accounting › Management of Technology and Innovation › Biotechnology and Related Fields
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
- Keywords
- active pharmaceutical ingredients, pharmaceutical excipients, reverse pharmacology, drug development, neglected diseases, regulatory approval, local pharmaceutical manufacturing, Africa
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
